Duncan Peyton
Founder presso 4D PHARMA PLC
Provenienza dei contatti di primo grado di Duncan Peyton
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
| Subsidiary | Miscellaneous Commercial Services | 9 | |
Aquarius Equity Partners Ltd.
 Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners Ltd is an independent private equity firm founded in the year 2002 by Alan John Aubrey and Duncan Joseph Peyton headquarters in the UK.
5
| Private Company | Investment Managers | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Duncan Peyton tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Proxima Corp.
 Proxima Corp. Computer PeripheralsElectronic Technology Part of Ask ASA, Proxima Corp. is a private company that makes multimedia projection products. The company is based in Wilsonville, OR. Proxima was acquired by Ask ASA on April 13, 1998 for $82.03 million. | Computer Peripherals | Chief Tech/Sci/R&D Officer | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JPMORGAN CHASE & CO. | Major Banks | Chief Tech/Sci/R&D Officer | |
SRA International, Inc.
 SRA International, Inc. Information Technology ServicesTechnology Services SRA International, Inc. provides technology and strategic consulting services and solutions. It offers information technology solutions and professional services that enable mission performance, improve efficiency of operations or reduce operating costs. The firm’s information technology service offerings include infrastructure services, software development, systems integration, cyber security, cloud computing, business intelligence, data analytics and mobile solutions. The company also provides mission-specific domain expertise in areas such as intelligence analysis, energy and environmental consulting, enterprise logistics and bioinformatics. The company was founded by Ernst Volgenau in 1978 and is headquartered in Fairfax, VA. | Information Technology Services | Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
Modern Biosciences Ltd.
 Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder | |
| TRACSIS PLC | Packaged Software | Director/Board Member | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Chairman Founder Director/Board Member | |
| IP GROUP PLC | Miscellaneous Commercial Services | Founder Chief Executive Officer Chief Investment Officer | |
Bristol-Myers Squibb Holdings Ltd.
 Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The private company is based in Uxbridge, UK. | Miscellaneous | Corporate Officer/Principal | |
NVM Private Equity LLP
 NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
| University of Leeds | College/University | Undergraduate Degree Doctorate Degree | |
Top Technology Ventures Ltd.
 Top Technology Ventures Ltd. Investment ManagersFinance Top Technology Ventures Ltd (TTV) is the venture capital subsidiary of IP Group Plc (LSE: IPO) founded in 1986. The firm is headquarters in London, UK. | Investment Managers | Private Equity Investor | |
| St. Bartholomew's Hospital | Corporate Officer/Principal | ||
| Jones International University | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Masters Business Admin | |
| University of Bristol | College/University | Undergraduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of St. Andrews | College/University | Doctorate Degree | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel | |
| Henley Management College | College/University | Masters Business Admin | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President | |
Diabetology Ltd.
 Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| DEEPMATTER GROUP PLC | Packaged Software | Director/Board Member Chairman | |
Salunda Ltd.
 Salunda Ltd. Electronic Equipment/InstrumentsElectronic Technology Salunda Ltd. develops market sensor technologies, equipment and fluid monitoring solutions for harsh environments. Its products can warn of imminent failure by detecting cracks, eccentric motion, orbiting, axial shift or vibration. The company was founded in 2005 and is headquartered in Bicester, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| TTV IV GP Ltd. | Director/Board Member Director/Board Member | ||
| XEROS TECHNOLOGY GROUP PLC | Industrial Machinery | Director/Board Member | |
Boxarr Ltd.
 Boxarr Ltd. Packaged SoftwareTechnology Services Boxarr Ltd. develops software for the aerospace and defense industries. Its services include consultancy, implementation, applications training, collaborative workshops, managed services, and standard support. It offers predictive analysis, optimise organizational performance, distributed supply chains, process and production, system design engineering, planning and execution, offset management, bid preparation, and joint operations solutions. The company was founded by Robert Smith, Steve Jonik, Ian Poccachard and Jim Scanlan in 2003 and is headquartered in Temple Meads, the United Kingdom. | Packaged Software | Director/Board Member | |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| TISSUE REGENIX GROUP PLC | Medical Specialties | Director/Board Member Director/Board Member | |
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The private company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Internet Software/Services | Director/Board Member Chairman Founder Chief Executive Officer | |
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Aquarius Life Science Ltd. | Director/Board Member | ||
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chairman | |
| ZYVERSA THERAPEUTICS, INC. | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 29 |
| Stati Uniti | 14 |
| Danimarca | 2 |
| Svizzera | 2 |
| Germania | 2 |
Settori
| Health Technology | 16 |
| Consumer Services | 8 |
| Finance | 6 |
| Technology Services | 6 |
| Commercial Services | 5 |
Posizioni
| Director/Board Member | 139 |
| Corporate Officer/Principal | 47 |
| Chairman | 32 |
| Independent Dir/Board Member | 30 |
| Founder | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Alan Aubrey | 52 |
| Paul Maier | 25 |
| David Robert Norwood | 22 |
| Trevor Nicholls | 19 |
| Alexander Stevenson | 19 |
| Charles Stephen Winward | 18 |
| Thomas Engelen | 16 |
| John W. Beck | 13 |
| Edgardo Baracchini | 13 |
| Katrin Rupalla | 13 |
| Axel Gaston Glasmacher | 9 |
| John Doyle | 7 |
| Alexander Macrae | 7 |
| Glenn Dourado | 7 |
| John D. Weinberg | 7 |
- Borsa valori
- Insiders
- Duncan Peyton
- Connessioni Società
